These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 17288950

  • 21. Delayed-enhancement MRI of apical hypertrophic cardiomyopathy: assessment of the intramural distribution and comparison with clinical symptoms, ventricular arrhythmias, and cine MRI.
    Amano Y, Takayama M, Fukushima Y, Kitamura M, Kumita S.
    Acta Radiol; 2011 Jul 01; 52(6):613-8. PubMed ID: 21498307
    [Abstract] [Full Text] [Related]

  • 22. Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatment.
    Weidemann F, Niemann M, Breunig F, Herrmann S, Beer M, Störk S, Voelker W, Ertl G, Wanner C, Strotmann J.
    Circulation; 2009 Feb 03; 119(4):524-9. PubMed ID: 19153271
    [Abstract] [Full Text] [Related]

  • 23. Stress hypoperfusion and tissue injury in hypertrophic cardiomyopathy: spatial characterization using high-resolution 3-tesla magnetic resonance imaging.
    Tyan CC, Armstrong S, Scholl D, Stirrat J, Blackwood K, El-Sherif O, Thompson T, Wisenberg G, Prato FS, So A, Lee TY, Drangova M, White JA.
    Circ Cardiovasc Imaging; 2013 Mar 01; 6(2):229-38. PubMed ID: 23413422
    [Abstract] [Full Text] [Related]

  • 24. Delayed hyper-enhancement of myocardium in hypertrophic cardiomyopathy with asymmetrical septal hypertrophy: comparison with global and regional cardiac MR imaging appearances.
    Amano Y, Takayama M, Takahama K, Kumazaki T.
    J Magn Reson Imaging; 2004 Oct 01; 20(4):595-600. PubMed ID: 15390225
    [Abstract] [Full Text] [Related]

  • 25. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans.
    Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, Elliott PM, McGregor C, Moon JC.
    Circulation; 2010 Jul 13; 122(2):138-44. PubMed ID: 20585010
    [Abstract] [Full Text] [Related]

  • 26. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.
    Roldán V, Marín F, Gimeno JR, Ruiz-Espejo F, González J, Feliu E, García-Honrubia A, Saura D, de la Morena G, Valdés M, Vicente V.
    Am Heart J; 2008 Jul 13; 156(1):85-91. PubMed ID: 18585501
    [Abstract] [Full Text] [Related]

  • 27. Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy.
    Maron MS, Appelbaum E, Harrigan CJ, Buros J, Gibson CM, Hanna C, Lesser JR, Udelson JE, Manning WJ, Maron BJ.
    Circ Heart Fail; 2008 Sep 13; 1(3):184-91. PubMed ID: 19808288
    [Abstract] [Full Text] [Related]

  • 28. Contrast-enhanced magnetic resonance imaging identifies focal regions of intramyocardial fibrosis in patients with severe aortic valve disease: Correlation with quantitative histopathology.
    Nigri M, Azevedo CF, Rochitte CE, Schraibman V, Tarasoutchi F, Pommerantzeff PM, Brandão CM, Sampaio RO, Parga JR, Avila LF, Spina GS, Grinberg M.
    Am Heart J; 2009 Feb 13; 157(2):361-8. PubMed ID: 19185646
    [Abstract] [Full Text] [Related]

  • 29. Delayed enhancement in hypertrophic cardiomyopathy: comparison with myocardial tagging MRI.
    Kim YJ, Choi BW, Hur J, Lee HJ, Seo JS, Kim TH, Choe KO, Ha JW.
    J Magn Reson Imaging; 2008 May 13; 27(5):1054-60. PubMed ID: 18425835
    [Abstract] [Full Text] [Related]

  • 30. Magnetic resonance imaging of apical left ventricular aneurysm and thinning associated with hypertrophic cardiomyopathy.
    Amano Y, Takayama M, Kumita S.
    J Comput Assist Tomogr; 2008 May 13; 32(2):259-64. PubMed ID: 18379313
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Cardiac magnetic resonance imaging findings are useful for differentiating between hypertrophic obstructive cardiomyopathy and aortic valve stenosis in elderly patients.
    Amano Y, Takayama M, Kumita S.
    J Comput Assist Tomogr; 2009 May 13; 33(3):354-8. PubMed ID: 19478626
    [Abstract] [Full Text] [Related]

  • 33. Significance of papillary muscle abnormalities identified by cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
    Harrigan CJ, Appelbaum E, Maron BJ, Buros JL, Gibson CM, Lesser JR, Udelson JE, Manning WJ, Maron MS.
    Am J Cardiol; 2008 Mar 01; 101(5):668-73. PubMed ID: 18308018
    [Abstract] [Full Text] [Related]

  • 34. Myocardial blood flow and fibrosis in hypertrophic cardiomyopathy.
    Aquaro GD, Todiere G, Barison A, Strata E, Marzilli M, Pingitore A, Lombardi M.
    J Card Fail; 2011 May 01; 17(5):384-91. PubMed ID: 21549295
    [Abstract] [Full Text] [Related]

  • 35. Hypertrophic cardiomyopathy, fibrosis, and aortic stiffness: an unidentified association unraveled by magnetic resonance imaging.
    Kühl HP.
    J Am Coll Cardiol; 2009 Jul 14; 54(3):263-4. PubMed ID: 19589440
    [No Abstract] [Full Text] [Related]

  • 36. Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations.
    Germans T, Wilde AA, Dijkmans PA, Chai W, Kamp O, Pinto YM, van Rossum AC.
    J Am Coll Cardiol; 2006 Dec 19; 48(12):2518-23. PubMed ID: 17174192
    [Abstract] [Full Text] [Related]

  • 37. Myocardial fibrosis in a patient with apical hypertrophic cardiomyopathy detected by delayed-enhanced magnetic resonance imaging.
    Sato Y, Matsumoto N, Kunimasa T, Matsuo S, Yoda S, Tani S, Kunimoto S, Saito S, Hirayama A.
    Int J Cardiol; 2008 Dec 17; 131(1):e41-3. PubMed ID: 17920709
    [Abstract] [Full Text] [Related]

  • 38. Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy.
    Teraoka K, Hirano M, Ookubo H, Sasaki K, Katsuyama H, Amino M, Abe Y, Yamashina A.
    Magn Reson Imaging; 2004 Feb 17; 22(2):155-61. PubMed ID: 15010107
    [Abstract] [Full Text] [Related]

  • 39. Abnormalities in T2-weighted cardiovascular magnetic resonance images of hypertrophic cardiomyopathy: regional distribution and relation to late gadolinium enhancement and severity of hypertrophy.
    Abdel-Aty H, Cocker M, Strohm O, Filipchuk N, Friedrich MG.
    J Magn Reson Imaging; 2008 Jul 17; 28(1):242-5. PubMed ID: 18581348
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.